Extracellular matrix tenascin‐X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
An extracellular matrix tenascin‐X (TNX) is highly expressed in muscular tissues, especially heart and skeletal muscle, and is also prominent around blood vessels. The precise in vivo role of TNX remains to be elucidated. To identify proteins that interact with TNX in the extracellular environment, we searched for TNX‐binding proteins using a yeast two‐hybrid system. We used mouse TNX‐specific fibronectin type III repeats (mTNX/FNIII 13‐25) as a bait for the screening. We found that vascular endothelial growth factor B (VEGF‐B) binds to mTNX/FNIII 13‐25. This interaction was confirmed by pull‐down assays and co‐immunoprecipitation assays. The full‐length mTNX, as well as mTNX/FNIII 13‐25, interacted with both alternative splice isoforms VEGF‐B 186 and VEGF‐B 167. Furthermore, the full‐length mTNX also bound to VEGF‐A. The minimal region of TNX that interacts with VEGF‐B was mapped to the FNIII repeats (FNIII 13‐25) but not to the other characteristic domains of TNX. The TNX‐binding site of VEGF‐B was located in the N‐terminal 115‐amino acid region. mTNX/FNIII 13‐25 did not prevent the interaction of VEGF‐B with VEGFR‐1 (VEGF receptor 1), and VEGF‐B could simultaneously bind to both mTNX/FNIII 13‐25 and VEGFR‐1. A conditioned medium from transfected 293T cells coexpressing full‐length TNX and VEGF‐B could promote DNA synthesis in bovine endothelial cells in which VEGFR‐1 were expressed. VEGFR‐1 phosphorylation triggered by VEGF‐B 186 were increased in cells plated with mTNX/FNIII 13‐25 or full‐length mTNX, compared with cells plated with VEGF‐B 186 alone. TNX interacts with VEGF‐B and enhances the ability of VEGF‐B to stimulate cell proliferation. This enhanced mitogenecity is caused by increased signals mediated by the VEGFR‐1 receptor. This finding suggests a role for TNX in the regulation of the development of blood vessels such as vasculogenesis and angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tenascin-X deficiency is associated with Ehlers-Danlos syndrome
Burch, G. H., Gong, Y., Liu, W., Dettman, R. W., Curry, C. J., Smith, L., Miller, W. L., & Bristow, J. (1997) · Nature Genetics · doi:10.1038/ng0997-104 · Cited by 366 · cited 1×
“However, a patient with both 21-hydroxylase deficiency and Ehlers±Danlos syndrome had an internal deletion including the C-terminal region of TNX, all of CYP21B and C4B genes (Burch et al. 1997).”
BackgroundTenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B
Bristow, J., Tee, M., Gitelman, S., Mellon, S., & Miller, W. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.1.265 · Cited by 302
Distinct Tissue Distribution in Pigs of Tenascin‐X and Tenascin‐C Transcripts
Geffrotin, C., Garrido, J. J., Tremet, L., & Vaiman, M. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0083f.x · Cited by 72 · cited 1×
“Unexpectedly, TNX is also expressed in peripheral nerves (Geffrotin et al. 1995).”
BackgroundCharacterization of the bovine Tenascin-X
Elefteriou, F., Exposito, J.-Y., Garrone, R., & Lethias, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22866 · Cited by 47 · cited 4×
“E-mail: kematsum@pharm.hokudai.ac.jp To date, the complete structure of TNX has been determined in the human (Bristow et al. 1993), bovine (Elefteriou et al. 1997), and mouse (Ikuta et al. 1998).”
BackgroundInfluential
Cited by
FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?
Fischer, C., Mazzone, M., Jonckx, B., & Carmeliet, P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2524 · Cited by 568
Nicolas, J., Magli, S., Rabbachin, L., Sampaolesi, S., Nicotra, F., & Russo, L. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00045 · Cited by 509
Regulation of angiogenesis by extracellular matrix
Sottile, J. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2003.07.002 · Cited by 288
ADAMTS1/METH1 Inhibits Endothelial Cell Proliferation by Direct Binding and Sequestration of VEGF165
Luque, A., Carpizo, D. R., & Iruela-Arispe, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212964200 · Cited by 263
Tenascin-X: beyond the architectural function
Valcourt, U., Alcaraz, L. B., Exposito, J.-Y., Lethias, C., & Bartholin, L. (2015) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.994893 · Cited by 132
Metadata
- Authors
- Ikuta, T., Ariga, H., & Matsumoto, K.
- Venue
- Genes to Cells
- Publisher
- Wiley
- Published
- 2000-11
- Volume
- 5
- Issue
- 11
- Pages
- 913-927
- ISSN
- 1356-9597 (ISSN-L)
- 1365-2443
- OpenAlex
- W2135442316
- Cited by
- 81
- References
- 4
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Extracellular matrix tenascin‐X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. https://app.cochat.ai/papers/10.1046/j.1365-2443.2000.00376.x
- The paper
- Ikuta, T., Ariga, H., & Matsumoto, K. (2000). Extracellular matrix tenascin‐X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes to Cells. https://doi.org/10.1046/j.1365-2443.2000.00376.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.